Live
- Crispin Chettri names 39 probables for AFC Women's Asian Cup 2026 Qualifiers
- First explain land-for-jobs scam: JD(U) leader Sanjay Jha hits back at Tejashwi
- Foreign investors infuse Rs 8,500 crore into Indian equities this week
- IPL 2025: KL Rahul becomes fastest Indian batter to hit 200 sixes in tournament history
- Was AI used in Jaideep Ahlawat's dance video? Co-actors Nikita Dutta, Kunal Kapoor reveal
- Two killed in multi-vehicle collision in Bihar's Muzaffarpur
- Madhuri Dixit to be part of Nadiadwala's next!
- HDFC Bank posts nearly 7 pc rise in net profit at Rs 17,616 crore in Q4
- 'Thug Life' is a peace offering to fans, says Kamal Haasan
- Alan Walker Sets Hyderabad Ablaze with Unforgettable Night on WalkerWorld India Tour
Strides acquires FDA-approved facility in US
Highlights
Bengaluru-headquartered Strides Pharma Science Limited on Tuesday announced that its step down subsidiary Strides Pharma Inc (SPI) has acquired a USFDA-approved manufacturing facility in Florida, USA, from Micelle BioPharma Inc.
Bengaluru: Bengaluru-headquartered Strides Pharma Science Limited on Tuesday announced that its step down subsidiary Strides Pharma Inc (SPI) has acquired a USFDA-approved manufacturing facility in Florida, USA, from Micelle BioPharma Inc.
Micelle's facility is based in Riviera Beach, Florida, and is one of the very few manufacturing facilities in the US with a softgel capsule (SGC) manufacturing suite for formulations with containment needs, Strides said.
Next Story
